This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Molina (MOH) to Buy AgeWell's Medicaid Long Term Care Business
by Zacks Equity Research
Molina (MOH) inks a deal to acquire certain assets of AgeWell New York's Medicaid Managed Care Business for a value of $110M.
Humana's (HUM) 2022 Expansion Plan to Boost MA Customer Base
by Zacks Equity Research
Humana (HUM) declares enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties to offer improved health outcomes.
Cigna (CI) Divests Unit to Chubb to Streamline Business
by Zacks Equity Research
Cigna (CI) sells its businesses to Chubb to focus on core growth areas.
Chubb (CB) to Strengthen Asia-Pacific Presence With Buyout
by Zacks Equity Research
Chubb (CB) will acquire Cigna's accident and health and life insurance operations in Korea, Taiwan, Hong Kong, New Zealand, Thailand and Indonesia as well as 51% stake in the Turkey joint venture.
Centene (CNC) Expands Medicare Advantage Offerings in 36 States
by Zacks Equity Research
Centene (CNC) boosts its Medicare Advantage offerings in 1,575 counties across 36 states in a bid to provide affordable and quality healthcare.
Cigna's (CI) 2022 Expansion Plans to Boost MA Customer Base
by Zacks Equity Research
Cigna (CI) unveils enhanced health plans for its customers to opt for in the 2022 Medicare AEP period. The company will foray into newer counties and states to offer enhanced health outcomes.
UnitedHealth (UNH) Woos MA Members With Updated 2022 Plans
by Zacks Equity Research
UnitedHealth (UNH) announces MA plans for 2022 to maintain its leadership position in the market.
Here's Why You Should Retain Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna (CI) is benefiting on the back of robust segmental performances and well-diversified healthcare suite. A strong partner network throughout U.S. is an added advantage.
Why Should You Stay Away From Teladoc Health (TDOC) Now?
by Zacks Equity Research
Rising competition and decreasing business volumes place Teladoc Health (TDOC) in a precarious position.
3 HMO Stocks That Outperformed the S&P Index in a Year's Time
by Srijita Guha
Membership growth, mergers and buyouts, and investment in technology are likely to aid health insurance companies like ANTM, MOH, and UNH to outperform the S&P Index.
Here is Why UnitedHealth (UNH) Should Grace Your Portfolio
by Zacks Equity Research
A solid positioning in an ever-growing industry makes UnitedHealth (UNH) a top pick for strong investment gains.
American Well (AMWL) Down 59% YTD: Should You Still Hold?
by Zacks Equity Research
American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.
Tenet Healthcare (THC) Expands Its Relationship With Cigna
by Zacks Equity Research
Tenet Healthcare (THC) stretches multi-year contract with Cigna to provide its in-network access to the latter's customers.
Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share
by Zacks Equity Research
Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.
Cigna (CI) Extends Tie-Up to Offer Better Care in Connecticut
by Zacks Equity Research
Cigna (CI) extends relationship with Hartford HealthCare to jointly offer enhanced healthcare services and thus, better health outcomes in Connecticut.
Cigna (CI) Expands Its Footprint in the ACA Marketplace
by Zacks Equity Research
Cigna (CI) expands its plan offerings on the Affordable Care Act's insurance exchanges, branching out into additional counties across three states for 2022.
Cigna (CI) Hikes Buyback Authorization, Boosts Shareholder Value
by Zacks Equity Research
Cigna's (CI) board raises share buyback authorization in an effort to support prudent capital deployment.
UnitedHealth (UNH) Hits 52-Week High: Hold it for Steady Growth
by Zacks Equity Research
UnitedHealth's (UNH) business diversification, presence in the niche markets and balance sheet strength make it a stock to be retained for long-term gains.
Molina (MOH) Arm's Medicaid Contract to Aid Service in Nevada
by Zacks Equity Research
Molina's (MOH) Nevada unit intends to improve the health outcomes of the state's Medicaid members through its recent contract win from the Nevada Department of Health and Human Services - DHCFP.
Centene (CNC) Nevada Unit Gets Contract to Aid Medicaid Members
by Zacks Equity Research
Centene's (CNC) recent contract win aims to enhance health outcomes for Medicaid members of Nevada.
Centene's (CNC) Contract Win to Aid Medicaid Members in Ohio
by Zacks Equity Research
Centene's (CNC) Ohio subsidiary intends to improve health outcomes of the state's Medicaid members through the recent contract win from the Ohio Department of Medicaid.
American Well (AMWL) Q2 Earnings Beat, 2H21 Visit View Cut
by Zacks Equity Research
American Well (AMWL) posts lower-than-expected loss for Q2. The spread of Delta variant compels the company to slash 2021 guidance.
Clover Health (CLOV) Stock Rises on Impressive Q2 Revenues
by Zacks Equity Research
Share value of Clover Health (CLOV) hits through the roof on the back of a solid revenue and earnings outlook.
Cigna (CI) Q2 Earnings Beat on Revenue Growth But Shares Fall
by Zacks Equity Research
Cigna's (CI) better-than-expected Q2 earnings benefit from better revenues, partly offset by higher medical cost.
Weekly Jobless Claims Decline
by Zacks Equity Research
Weekly Jobless Claims Decline